NL-OMON47731
Completed
Not Applicable
European Prevention of Alzheimer's Dementia - Longitudinal Cohort Study (EPAD-LCS) - EPAD-LCS
niversity of Edinburgh0 sites200 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alzheimer's dementia
- Sponsor
- niversity of Edinburgh
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age at least 50 years, checked and recorded at screening (Visit 1\) only.
- •Fulfils the criteria set by the Balancing Committee \[BC]
- •Able to read and write and with minimum 5 years of formal education, checked
- •and recorded at screening (Visit 1\) only.
- •Willing in principle to participate in the EPAD PoC trial subject to further
- •informed consent
- •Have a study partner or can identify someone willing in principle to be a
- •study partner
Exclusion Criteria
- •Research participants who fulfil diagnostic criteria for any type of dementia
- •(e.g. National Institute of Neurological and Communicative Disorders and Stroke
- •and Alzheimer's Disease and Related Disorders Association \[NINCDS\-ADRDA] for
- •AD; Lund Criteria for fronto\-temporal dementia \[FTD], McKeith Criteria for
- •dementia with Lewy bodies \[DLB], National Institute of Neurological Disorders
- •and Stroke and Association Internationale pour la Recherché et l'Enseignement
- •en Neurosciences \[NINCDS\-AIREN] Criteria for Vascular Dementia)
- •CDR \>\=\>\=1 at screening (Visit 1\)
- •Known carriers of a Presenilin (PSEN) PSEN1, PSEN2 or APP mutation associated
- •with Autosomal Dominant AD or any other neurodegenerative disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The prevention of Alzheimer's disease through regulation of amyloid beta synthesis and brake-down by propolis intaketype 2 diabetes dementiaJPRN-UMIN000015423Kyoto Prefectural University of Medicine, Graduate School of Medical Science60
Not yet recruiting
Phase 1
Study on prevention mild to moderate Alzheimer's disease from exacerbating through invigorating spleen and kidneyAlzheimer's diseaseITMCTR2200006842onghua Hospital Shanghai University of Traditional Chinese Medicine
Completed
Not Applicable
PrepAD Study: Prepare for Alzheimer Dementia. Effectiveness of an online self-management program for family caregivers of patients with (very) early-stage dementia including prodromal dementia (Mild Cognitive Impairment due to AD)geen aandoeningen, zelfvertrouwen en psychische belasting/stress bij familieleden van mensen met dementie in een vroeg stadium (inclusief prodromale dementieMCI due to AD)caregiver self-efficacy and perceived control + burden/stress in family members of MCI/early-stage dementia patientsNL-OMON42080Medisch Universitair Ziekenhuis Maastricht80
Completed
Phase 3
A Phase III Trial of Nilvadipine to Treat Alzheimer's DiseaseAlzheimer's DiseaseNCT02017340Prof Brian Lawlor511
Completed
Not Applicable
Danish Alzheimer Intervention StudYDementia and Alzheimer's diseaseNervous System DiseasesDementia in Alzheimer's diseaseISRCTN74848736Memory Disorders Research Group (Denmark)330